Rosuvastatin calcium in acute coronary syndromes

Comparison of Lipid-Modifying Efficacy of Rosuvastatin Versus Atorvastatin in Patients With Acute Coronary Syndrome (from the LUNAR Study)

(2012) Bertram Pitt et al.   AMERICAN JOURNAL OF CARDIOLOGY

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

(2012) et al.   CIRCULATION

Effects of Rosuvastatin and Atorvastatin on Renal Function

(2012) Yongxia Wu et al.   CIRCULATION JOURNAL

Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study

(2012) Claire Meek et al.   CURRENT MEDICAL RESEARCH AND OPINION

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia

(2012) Eli M. Roth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intensive Lipid-Lowering Therapy With Rosuvastatin Stabilizes Lipid-Rich Coronary Plaques

(2011) Tsunenari Soeda et al.   CIRCULATION JOURNAL

Early Intervention With Rosuvastatin Decreases the Lipid Components of the Plaque in Acute Coronary Syndrome

(2011) Kyuhachi Otagiri et al.   CIRCULATION JOURNAL

Atorvastatin and Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus Patients on Hemodialysis

(2011) W. Marz et al.   Clinical Journal of the American Society of Nephrology

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

(2011) et al.   EUROPEAN HEART JOURNAL

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

(2011) Stephen J. Nicholls et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

(2010) Michael S. Kostapanos et al.   American Journal of Cardiovascular Drugs

Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: Results of the CENTAURUS study

(2010) Jean-Marc Lablanche et al.   Archives of Cardiovascular Diseases

Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction

(2010) Kristian M. Bailey et al.   Circulation-Cardiovascular Genetics

Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)

(2010) K. A. A. Fox et al.   EUROPEAN HEART JOURNAL

12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome

(2010) Kyeong Ho Yun et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Effect of Rosuvastatin on Coronary Atheroma in Stable Coronary Artery Disease

(2009) Tadateru Takayama et al.   CIRCULATION JOURNAL

A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events – Reduction of Cholesterol to Key European Targets Trial

(2009) Alistair S. Hall et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

(2009) C. Michael Gibson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin: efficacy, safety and clinical effectiveness

(2008) Handrean Soran et al.   EXPERT OPINION ON PHARMACOTHERAPY

The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome

(2008) Kyeong Ho Yun et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intravenous Rosuvastatin for Acute Stroke Treatment

(2007) Vincent Prinz et al.   STROKE